Hostname: page-component-cd9895bd7-jkksz Total loading time: 0 Render date: 2024-12-23T07:22:02.845Z Has data issue: false hasContentIssue false

Reply to Drekonja

Published online by Cambridge University Press:  02 January 2015

Stuart H. Cohen
Affiliation:
Department of Internal Medicine, Division of Infectious and Immunologic Diseases, University of California Davis Medical Center, Sacramento
Dale N. Gerding
Affiliation:
Research Service, Edward Hines Jr Veterans Administration Hospital, and the Infectious Disease Division, Department of Medicine, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois
Stuart Johnson
Affiliation:
Research Service, Edward Hines Jr Veterans Administration Hospital, and the Infectious Disease Division, Department of Medicine, Loyola University Chicago Stritch School of Medicine, Maywood, Illinois
Rights & Permissions [Opens in a new window]

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Letters to the Editor
Copyright
Copyright © The Society for Healthcare Epidemiology of America 2010

References

1.Drekonja, DM. Rifampin plus metronidazole for Clostridium difficile infection. Infect Control Hosp Epidemiol 2010;31(11):1205 (in this issue).CrossRefGoogle ScholarPubMed
2.Lagrotteria, D, Holmes, S, Smieja, M, Smaili, F, Lee, C. Prospective, randomized inpatient study of oral metronidazole versus oral metronidazole and rifampin for treatment of primary episode of Clostridium difficile-associated diarrhea. Clin Infect Dis 2006;43:547552.CrossRefGoogle ScholarPubMed
3.Cohen, SH, Gerding, DN, Johnson, S, et al.Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Healthcare Epidemiology of America (SHEA) and the Infectious Diseases Society of America (IDSA). Infect Control Hosp Epidemiol 2010;31(11):431455.Google Scholar